SEC Form 4 · accession 0001214659-16-011132
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David E. Thompson
Director
Period of report
Apr 27, 2016
Accepted (ET)
Apr 29, 2016 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.80 | Apr 27, 2016 | A | 41,379 | A | — | Apr 27, 2026 | Common Stock | 41,379 | 41,379 | D |
Explanation of responses
- F1This non-statutory stock option vests and becomes exercisable in 12 equal monthly installments from the vesting commencement date of April 27, 2016 and will be fully exercisable on April 27, 2017.